Order Article Reprints

Lee M-G, Lee Y-K, Huang S-C, Chang C-L, Ko C-Y, Lee W-C, Chen T-Y, Tzou S-J, Huang C-Y, Tai M-H, et al. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes. 2022; 13(4):629. https://doi.org/10.3390/genes13040629

Lee, Man-Gang, Yung-Kuo Lee, Shih-Chung Huang, Chen-Lin Chang, Chou-Yuan Ko, Wen-Chin Lee, Tung-Yuan Chen, Shiow-Jyu Tzou, Cheng-Yi Huang, Ming-Hong Tai, and et al. 2022. "DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis" Genes 13, no. 4: 629. https://doi.org/10.3390/genes13040629

Lee, M.-G., Lee, Y.-K., Huang, S.-C., Chang, C.-L., Ko, C.-Y., Lee, W.-C., Chen, T.-Y., Tzou, S.-J., Huang, C.-Y., Tai, M.-H., Lin, Y.-W., Kung, M.-L., Tsai, M.-C., Chen, Y.-L., Chang, Y.-C., Wen, Z.-H., Huang, C.-C., & Chu, T.-H. (2022). DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis. Genes, 13(4), 629. https://doi.org/10.3390/genes13040629